search
Back to results

Spinal Stimulation in Chronic Spinal Cord Injury

Primary Purpose

Spinal Cord Injuries

Status
Completed
Phase
Not Applicable
Locations
United Kingdom
Study Type
Interventional
Intervention
Transcutaneous spinal cord stimulation
Activity Based Therapy
Sponsored by
The Neurokinex Charitable Trust
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Spinal Cord Injuries

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Participant is willing and able to give informed consent for participation in the study
  • Aged 18 years or over
  • Injury level C4-T12
  • At least one year post spinal cord injury
  • Medically stable and cognitively intact
  • Independent respiration, not requiring any ventilatory support

Exclusion Criteria:

  • Any active implanted metallic device including, but not limited to neurostimulators, cochlear implants, pacemakers, implantable defibrillators or drug delivery pump
  • Implanted surgical hardware that is not compatible with MRI scanners
  • Possible, suspected or confirmed pregnancy and/or lactation
  • Active Heterotopic Ossification
  • Recent history or fracture, contractures or pressure sore, deep vein thrombosis or urinary tract or other infection that may interfere with the intervention and training.
  • History of epilepsy and/or seizures.
  • Severe spasticity which have been unstable over the past 3 months prior to enrolment and not expected to change; taking varying doses of anti-spasticity medications which could not be tapered to a stable dose and is not expected to change
  • Botulinum toxin injections within 6 months of participation (excluding bladder)
  • Non-injury related neurological impairment
  • Clinically significant severe depression in spite of treatment
  • Patients who have cardiovascular disease
  • Patients with Autonomic Dysreflexia that is severe, ongoing and has required medical treatment within the past one month
  • Active aggressive tumour within or surrounding the spinal cord or brain stem
  • A syrinx (fluid filled cavity) in the spinal cord
  • Skin conditions or allergies that may affect electrode placement
  • Bodyweight over 120kg (due to inability to use some of the study equipment)
  • Patients who do not understand English

Sites / Locations

  • Neurokinex
  • Neurokinex

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm Type

Experimental

Experimental

Experimental

Arm Label

Motor Complete Tetraplegia

Motor Complete Paraplegia

Motor incomplete SCI

Arm Description

C4-T1 American Spinal Injuries Association (ASIA) Impairment Scale Classification A or B spinal cord injury tscs with activity based therapy intervention

T2-12 ASIA Impairment Scale A or B spinal cord injury tscs with activity based therapy intervention

C4-T12 ASIA Impairment Scale C or D spinal cord injury tscs with activity based therapy intervention

Outcomes

Primary Outcome Measures

International Standards for the Neurological Classification of Spinal Cord Injury Classification scores (ISNCSCI ASIA chart)
Sensory and motor scores. Sensory scale 0-224, motor scale 0-100 with higher scores relating to increased sensation and motor power
Spinal Cord Independence Measure (SCIM)
Functional independence tool for spinal cord injury. Scale of 0-100, with higher scores meaning increased function
Berg Balance Score (where applicable)
Measure of standing balance. Scale of 0-56, with higher values meaning increased standing balance and reduced risk of falls
NeuroRecovery Scale (NRS)
Functional independence measure rated from 1a, the lowest classification of functioning to 4C, the highest classification of functioning
Graded Redefined Assessment of Strength, Sensation and Prehension (GRASSP) Test
Upper limb measure of sensation and function. Strength scored 0-100, sensation scored 0-24 and prehension scored 0-64. Increased score relates to increased hand strength, sensation and function
Capabilities of Upper Extremity Questionnaire (CUE)
Upper limb capability questionnaire with 32 items. Scores between 32-124 with higher scores associated with higher levels of function of the upper limb
Force dynamometry - hand
Grip and pinch strength using JTech force transducers. Measurements taken in Newtons
Electromyography (EMG) of muscle activity
Upper limb, trunk and lower limb EMG using the Delsys Trigno System

Secondary Outcome Measures

World Health Organisation Quality Of Life - BREF (WHOQOL-BREF)
Quality of Life self report questionnaire with 26 items, subdivided into Physical Health (raw score range 7-35), Psychological Health (raw score range 6-30), Social Relationships (raw score range 3-15), Environment (raw score range 8-40)
International Spinal Cord Society Autonomic Standards Assessment Form
Bladder function questionnaire to document method of bladder management
International Spinal Cord Society Autonomic Standards Assessment Form
Bowel function questionnaire to document method of bowel management
International Spinal Cord Society Autonomic Standards Assessment Form
Cardiovascular function questionnaire to document ability to regulate cardiovascular system
International Spinal Cord Society Autonomic Standards Assessment Form
Sexual function questionnaire to document symptoms and impairments resulting from spinal cord injury
Modified Ashworth Scale
Spasticity measure, scores of 0 - no increase in spasticity to 4 - affected part rigid
Respiratory function tests of maximal inspiratory and expiratory pressures
Maximal inspiratory and expiratory pressures in breathing,

Full Information

First Posted
October 17, 2019
Last Updated
December 28, 2022
Sponsor
The Neurokinex Charitable Trust
Collaborators
International Spinal Research Trust
search

1. Study Identification

Unique Protocol Identification Number
NCT04132596
Brief Title
Spinal Stimulation in Chronic Spinal Cord Injury
Official Title
Non-invasive Spinal Cord Stimulation Combined With Activity-based Rehabilitation in Chronic Spinal Cord Injury
Study Type
Interventional

2. Study Status

Record Verification Date
December 2022
Overall Recruitment Status
Completed
Study Start Date
November 11, 2019 (Actual)
Primary Completion Date
October 3, 2022 (Actual)
Study Completion Date
October 3, 2022 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
The Neurokinex Charitable Trust
Collaborators
International Spinal Research Trust

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
Yes
Device Product Not Approved or Cleared by U.S. FDA
Yes
Product Manufactured in and Exported from the U.S.
Yes
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
Electrical spinal stimulation combined with activity-based rehabilitation (ABR) can improve motor and autonomic function in individuals suffering from varying degrees of paralysis. Spinal stimulation studies have included invasive implanted devices and non-invasive transcutaneous systems using different combinations of stimulation current, waveform, amplitude, duration and spinal levels targeted. Invasive and non-invasive systems have been demonstrated to permit individuals with chronic spinal cord injury (SCI), previously considered to have complete injuries on the International Standards for the Neurological Classification of Spinal Cord Injuries (ISNCSCI) scale (Classification A), to regain some degree of voluntary and autonomic function during periods of stimulation. The aim of this study is to evaluate the effects of a novel non-invasive transcutaneous electrical spinal cord stimulation system (tSCS) combined with activity-based rehabilitation in patients who have paralysis of their legs and/or arms. We will examine participants for any changes in sensory, motor or autonomic function. We will use a transcutaneous spinal cord stimulator that has been designed to deliver safe and tolerable bursts of high frequency pulsed current that minimise the capacitance efforts of the skin surface and maximise conductance of a second waveform using low frequency current to target neural structures. We aim to investigate this form of neuromodulation with a small group of individuals with chronic spinal cord injury. Our goal is to observe and describe any short term or lasting changes in function that can safely and comfortably be derived from this combination of spinal stimulation and activity-based rehabilitation. If this therapy can cause lasting improvements in sensory, motor, respiratory or autonomic function, then this may lead to a greater degree of functional independence for these individuals.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Spinal Cord Injuries

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Model Description
Cohort study
Masking
None (Open Label)
Allocation
Non-Randomized
Enrollment
12 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Motor Complete Tetraplegia
Arm Type
Experimental
Arm Description
C4-T1 American Spinal Injuries Association (ASIA) Impairment Scale Classification A or B spinal cord injury tscs with activity based therapy intervention
Arm Title
Motor Complete Paraplegia
Arm Type
Experimental
Arm Description
T2-12 ASIA Impairment Scale A or B spinal cord injury tscs with activity based therapy intervention
Arm Title
Motor incomplete SCI
Arm Type
Experimental
Arm Description
C4-T12 ASIA Impairment Scale C or D spinal cord injury tscs with activity based therapy intervention
Intervention Type
Device
Intervention Name(s)
Transcutaneous spinal cord stimulation
Intervention Description
Electrical stimulation of the spinal cord via transcutaneous hydrogel electrodes
Intervention Type
Other
Intervention Name(s)
Activity Based Therapy
Intervention Description
Physical therapy
Primary Outcome Measure Information:
Title
International Standards for the Neurological Classification of Spinal Cord Injury Classification scores (ISNCSCI ASIA chart)
Description
Sensory and motor scores. Sensory scale 0-224, motor scale 0-100 with higher scores relating to increased sensation and motor power
Time Frame
1 year
Title
Spinal Cord Independence Measure (SCIM)
Description
Functional independence tool for spinal cord injury. Scale of 0-100, with higher scores meaning increased function
Time Frame
1 year
Title
Berg Balance Score (where applicable)
Description
Measure of standing balance. Scale of 0-56, with higher values meaning increased standing balance and reduced risk of falls
Time Frame
1 year
Title
NeuroRecovery Scale (NRS)
Description
Functional independence measure rated from 1a, the lowest classification of functioning to 4C, the highest classification of functioning
Time Frame
1 year
Title
Graded Redefined Assessment of Strength, Sensation and Prehension (GRASSP) Test
Description
Upper limb measure of sensation and function. Strength scored 0-100, sensation scored 0-24 and prehension scored 0-64. Increased score relates to increased hand strength, sensation and function
Time Frame
1 year
Title
Capabilities of Upper Extremity Questionnaire (CUE)
Description
Upper limb capability questionnaire with 32 items. Scores between 32-124 with higher scores associated with higher levels of function of the upper limb
Time Frame
1 year
Title
Force dynamometry - hand
Description
Grip and pinch strength using JTech force transducers. Measurements taken in Newtons
Time Frame
1 year
Title
Electromyography (EMG) of muscle activity
Description
Upper limb, trunk and lower limb EMG using the Delsys Trigno System
Time Frame
1 year
Secondary Outcome Measure Information:
Title
World Health Organisation Quality Of Life - BREF (WHOQOL-BREF)
Description
Quality of Life self report questionnaire with 26 items, subdivided into Physical Health (raw score range 7-35), Psychological Health (raw score range 6-30), Social Relationships (raw score range 3-15), Environment (raw score range 8-40)
Time Frame
1 year
Title
International Spinal Cord Society Autonomic Standards Assessment Form
Description
Bladder function questionnaire to document method of bladder management
Time Frame
1 year
Title
International Spinal Cord Society Autonomic Standards Assessment Form
Description
Bowel function questionnaire to document method of bowel management
Time Frame
1 year
Title
International Spinal Cord Society Autonomic Standards Assessment Form
Description
Cardiovascular function questionnaire to document ability to regulate cardiovascular system
Time Frame
1 year
Title
International Spinal Cord Society Autonomic Standards Assessment Form
Description
Sexual function questionnaire to document symptoms and impairments resulting from spinal cord injury
Time Frame
1 year
Title
Modified Ashworth Scale
Description
Spasticity measure, scores of 0 - no increase in spasticity to 4 - affected part rigid
Time Frame
1 year
Title
Respiratory function tests of maximal inspiratory and expiratory pressures
Description
Maximal inspiratory and expiratory pressures in breathing,
Time Frame
1 year

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Participant is willing and able to give informed consent for participation in the study Aged 18 years or over Injury level C4-T12 At least one year post spinal cord injury Medically stable and cognitively intact Independent respiration, not requiring any ventilatory support Exclusion Criteria: Any active implanted metallic device including, but not limited to neurostimulators, cochlear implants, pacemakers, implantable defibrillators or drug delivery pump Implanted surgical hardware that is not compatible with MRI scanners Possible, suspected or confirmed pregnancy and/or lactation Active Heterotopic Ossification Recent history or fracture, contractures or pressure sore, deep vein thrombosis or urinary tract or other infection that may interfere with the intervention and training. History of epilepsy and/or seizures. Severe spasticity which have been unstable over the past 3 months prior to enrolment and not expected to change; taking varying doses of anti-spasticity medications which could not be tapered to a stable dose and is not expected to change Botulinum toxin injections within 6 months of participation (excluding bladder) Non-injury related neurological impairment Clinically significant severe depression in spite of treatment Patients who have cardiovascular disease Patients with Autonomic Dysreflexia that is severe, ongoing and has required medical treatment within the past one month Active aggressive tumour within or surrounding the spinal cord or brain stem A syrinx (fluid filled cavity) in the spinal cord Skin conditions or allergies that may affect electrode placement Bodyweight over 120kg (due to inability to use some of the study equipment) Patients who do not understand English
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Jane Symonds, Physio
Organizational Affiliation
Clinical Lead Physiotherapist
Official's Role
Principal Investigator
Facility Information:
Facility Name
Neurokinex
City
Gatwick
ZIP/Postal Code
RH10 9NE
Country
United Kingdom
Facility Name
Neurokinex
City
Hemel Hempstead
ZIP/Postal Code
HP2 7BW
Country
United Kingdom

12. IPD Sharing Statement

Plan to Share IPD
No
Links:
URL
http://www.neurokinex.org
Description
Related Info

Learn more about this trial

Spinal Stimulation in Chronic Spinal Cord Injury

We'll reach out to this number within 24 hrs